OverviewSuggest Edit

Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. The Company develops and commercializes products both within Fortress and through certain of its subsidiary companies, also known as Fortress Companies. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities. 

... Show more
TypePublic
Founded2006
HQNew York, US
Websitefortressbiotech.com

Latest Updates

Employees (est.) (Sep 2017)45
Job Openings1
Revenue (FY, 2017)$187.6 M(+1039%)
Share Price (Feb 2019)$2.2

Fortress Biotech Office Locations

Fortress Biotech has an office in New York
New York, US (HQ)
2 Gansevoort St
Show all (1)
Report incorrect company information

Fortress Biotech Financials and Metrics

Fortress Biotech Revenue

Fortress Biotech's revenue was reported to be $187.58 m in FY, 2017
USD

Revenue (Q3, 2018)

63.7m

Net income (Q3, 2018)

(28.6m)

EBIT (Q3, 2018)

(24.9m)

Market capitalization (15-Feb-2019)

123.6m

Closing stock price (15-Feb-2019)

2.2

Cash (30-Sep-2018)

95.9m
Fortress Biotech's current market capitalization is $123.6 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Revenue

273.0k16.5m187.6m

Revenue growth, %

1810%

Sales and marketing expense

5.4m96.8m

General and administrative expense

10.1m21.6m28.2m40.5m
Quarterly
USDQ3, 2013Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

383.0k2.2m975.0k44.7m50.7m46.9m55.4m63.8m63.7m

Sales and marketing expense

24.5m24.0m24.9m25.6m31.4m28.4m

General and administrative expense

2.1m2.1m2.7m3.5m3.8m7.1m7.9m8.6m8.9m8.0m8.5m12.3m10.8m10.1m12.2m

R&D expense

5.4m4.5m1.6m1.6m2.4m9.1m7.7m6.3m7.3m8.4m11.7m15.9m12.0k17.5m16.1m
Annual
USDFY, 2013FY, 2015FY, 2016

Cash

99.5m98.2m88.3m

Accounts Receivable

1.8m

Inventories

1.6m203.0k

Current Assets

100.0m99.8m109.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

106.3m80.0m75.8m71.6m48.9m41.0m25.6m81.4m71.3m82.5m134.0m144.3m110.5m124.0m98.6m95.9m

Accounts Receivable

967.0k5.0m1.4m3.3m5.6m8.3m5.3m5.4m

Inventories

100.0k123.0k204.0k299.0k318.0k222.0k299.0k674.0k

Current Assets

106.5m80.5m76.5m72.1m69.6m62.0m66.6m84.3m76.6m98.6m151.8m190.2m184.1m200.2m171.5m159.5m
Annual
USDFY, 2013FY, 2015FY, 2016

Net Income

(37.2m)(53.9m)(71.3m)

Depreciation and Amortization

17.0k944.0k

Inventories

(895.0k)(203.0k)

Accounts Payable

1.2m5.9m5.4m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(27.4m)(7.4m)(16.7m)(12.5m)(19.0m)(19.9m)(16.6m)(33.0m)(50.0m)(14.6m)(37.5m)(73.8m)(38.2m)(73.9m)(102.5m)

Depreciation and Amortization

11.0k5.0k11.0k17.0k11.0k4.0k74.0k240.0k682.0k543.0k819.0k365.0k831.0k1.4m

Inventories

(100.0k)(123.0k)(1.0k)(96.0k)(115.0k)(51.0k)(128.0k)(503.0k)

Accounts Payable

252.0k(588.0k)(1.5m)(1.4m)664.0k920.0k1.3m169.0k3.6m5.4m(1.9m)(1.7m)4.2m8.3m1.2m(980.0k)
USDY, 2018

Financial Leverage

2.7 x
Show all financial metrics
Report incorrect company information

Fortress Biotech Online and Social Media Presence

Embed Graph
Report incorrect company information

Fortress Biotech News and Updates

Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals

Fortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee

Fortress Biotech Recaps Corporate Highlights and Achievements in 2018

NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today recapped its corporate highlights and achievements in 2018.

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that it has entered into an agreement to sell its 56.1…

Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced financial results and recent corporate highlights for …
Report incorrect company information

Fortress Biotech Company Life and Culture

Report incorrect company information

Fortress Biotech Frequently Asked Questions

  • When was Fortress Biotech founded?

    Fortress Biotech was founded in 2006.

  • How many employees does Fortress Biotech have?

    Fortress Biotech has 45 employees.

  • What is Fortress Biotech revenue?

    Latest Fortress Biotech annual revenue is $187.6 m.

  • What is Fortress Biotech revenue per employee?

    Latest Fortress Biotech revenue per employee is $4.2 m.

  • Who are Fortress Biotech competitors?

    Competitors of Fortress Biotech include Origene Technologies, Aptuit and Kezar Life Sciences.

  • Where is Fortress Biotech headquarters?

    Fortress Biotech headquarters is located at 2 Gansevoort St, New York.

  • Where are Fortress Biotech offices?

    Fortress Biotech has an office in New York.

  • How many offices does Fortress Biotech have?

    Fortress Biotech has 1 office.